Institutional Biosafety Committee (IBC)
COVID-19 FAQs regarding deferring research
Agencies and Regulations for Recombinant DNA Research
The Institutional Biosafety Committee (IBC) is charged with reviewing protocols for research and teaching that involve the use of recombinant DNA (rDNA) subject to the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), infectious biological agents, and biohazardous agents at Caltech. Committee oversight helps to ensure that all research protocols involving biohazardous materials and the facilities used to conduct the research are in compliance with existing government regulations and applicable Caltech policies.
The IBC membership is constituted in accordance with the NIH Guidelines and the IBC meets monthly to review protocols proposing use of recombinant DNA and biohazards.
The IBC interfaces frequently with the Institute Animal Care and Use Committee, the Institutional Review Board, the stem cell committee, and radiation safety.